As of January 22, 2025, Korro Bio (KRRO) has a market cap of $0.36 billion USD. According to our data, Korro Bio is ranked No.6487 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.36 B |
0.11%
|
Dec 31, 2024 | $0.36 B |
-20.57%
|
Dec 29, 2023 | $0.45 B |
-75.10%
|
Dec 30, 2022 | $1.80 B |
-24.95%
|
Dec 31, 2021 | $2.40 B |
-85.45%
|
Dec 31, 2020 | $16.52 B |
101.14%
|
Dec 31, 2019 | $8.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
Verve Therapeutics
VERV
|
$0.66 B |
0.000 M
|
USA
|
Market Cap | = | KRRO Stock Price | * | KRRO Shares Outstanding |
= | $38.11 | * | 9.37 M | |
= | $0.36 B |